Answers are grounded in this paper and cite their sources.
Review examines fNIRS-informed tPBM for optimizing brain function in neuropsychiatric disorders, suggesting new personalized approaches.
Neuropsychiatric disorders involve heterogeneous alterations in brain functional states, hemodynamic regulation, and network-level dynamics. Their assessment and therapeutic optimization may therefore benefit from approaches that capture neurophysiological dynamics and accommodate interindividual variability. Functional near-infrared spectroscopy (fNIRS) provides a portable, non-invasive modality for monitoring cortical hemodynamic activity and extracting brain-state-related features, whereas transcranial photobiomodulation (tPBM) has been investigated as a light-based neuromodulatory intervention that may influence mitochondrial bioenergetics, cerebral metabolism, neuroinflammatory processes, and large-scale brain networks. From a methodological and translational perspective, this review examines fNIRS-informed personalized tPBM as an emerging framework for coordinating brain-state sensing, optical-dose and target planning, decision-making, response monitoring, and longitudinal protocol refinement. The discussion is organized around three interrelated components essential for personalized neuromodulation: brain-state sensing, decision-making, and feedback-informed modulation. The utility of fNIRS is first examined for monitoring cerebral functional states, extracting hemodynamic and network-level features, and characterizing interindividual variability relevant to neuromodulation. The biophysical mechanisms and clinical evidence of tPBM are then critically evaluated, with particular attention to heterogeneous therapeutic outcomes, mixed findings from controlled trials, variability in stimulation parameters, uncertainty in target engagement, limitations of sham controls, and the limitations of existing open-loop paradigms. We discuss how fNIRS-derived hemodynamic and network-level features could support personalized tPBM by informing target selection, individualized dose planning, treatment-response monitoring and longitudinal protocol refinement. Because fNIRS signals are delayed, noise-sensitive and susceptible to extracerebral contamination and optical crosstalk during integration with tPBM, this approach should currently be viewed as a feedback-informed personalization strategy rather than an autonomous real-time closed-loop therapy. We also outline the methodological requirements for clinical translation, including target-engagement validation, individualized optical dosimetry, signal-quality control, interference mitigation, decision-algorithm validation and clinical standardization.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: